Astra Cleared by U.S. Regulators to Resume Vaccine Trial

Bookmark
(Bloomberg) -- AstraZeneca Plc, the U.K. drugmaker developing a Covid-19 vaccine with the University of Oxford, has been cleared by U.S. regulators to restart a trial halted in the country for more...
BQ Install

Bloomberg Quint

Add BloombergQuint App to Home screen.